{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:58:41Z","timestamp":1791179921080,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,10,3]],"date-time":"2007-10-03T00:00:00Z","timestamp":1191369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s00424-007-0340-1","type":"journal-article","created":{"date-parts":[[2007,10,2]],"date-time":"2007-10-02T11:07:11Z","timestamp":1191323231000},"page":"839-847","source":"Crossref","is-referenced-by-count":47,"title":["The Wilms\u2019 tumor suppressor WT1 is associated with melanoma proliferation"],"prefix":"10.1007","volume":"455","author":[{"given":"Nicole","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Panelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Massi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay-Dietrich","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,3]]},"reference":[{"key":"340_CR1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0190-9622(90)70214-3","volume":"23","author":"VA Albert","year":"1990","unstructured":"Albert VA, Koh HK, Geller AC, Miller DR, Prout MN, Lew RA (1990) Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society. J Am Acad Dermatol 23:308\u2013310","journal-title":"J Am Acad Dermatol"},{"key":"340_CR2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","volume":"44","author":"M Al-Hussaini","year":"2004","unstructured":"Al-Hussaini M, Stockman A, Foster H, McCluggage WG (2004) WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology 44:109\u2013115","journal-title":"Histopathology"},{"key":"340_CR3","first-page":"344","volume":"146","author":"KM Amin","year":"1995","unstructured":"Amin KM, Litzky LA, Smythe WR, Mooney AM, Morris JM, Mews DJ, Pass HI, Kari C, Rodeck U, Rauscher FJ, 3rd et al (1995) Wilms\u2019 tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol 146:344\u2013356","journal-title":"Am J Pathol"},{"key":"340_CR4","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A, Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635\u20133648","journal-title":"J Clin Oncol"},{"key":"340_CR5","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2741\/1877","volume":"11","author":"M Berwick","year":"2006","unstructured":"Berwick M, Wiggins C (2006) The current epidemiology of cutaneous malignant melanoma. Front Biosci 11:1244\u20131254","journal-title":"Front Biosci"},{"key":"340_CR6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.bjc.6602321","volume":"92","author":"NG Burnet","year":"2005","unstructured":"Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP (2005) Years of life lost (YLL) from cancer is an important measure of population burden-and should be considered when allocating research funds. Br J Cancer 92:241\u2013245","journal-title":"Br J Cancer"},{"key":"340_CR7","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1038\/sj.onc.1210127","volume":"26","author":"EA Burwell","year":"2007","unstructured":"Burwell EA, McCarty GP, Simpson LA, Thompson KA, Loeb DM (2007) Isoforms of the Wilms\u2019 tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells. Oncogene 26:3423\u201330","journal-title":"Oncogene"},{"issue":"2","key":"340_CR8","first-page":"354","volume":"54","author":"VA Florenes","year":"1994","unstructured":"Florenes VA, Holm R, Myklebost O, Lendahl U, Fodstad O (1994) Expression of the neuroectodermal intermediate filament nestin in human melanomas. Cancer Res 54(2):354\u2013356","journal-title":"Cancer Res"},{"key":"340_CR9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.5858\/2001-125-1316-IAONVC","volume":"125","author":"MR Foster","year":"2001","unstructured":"Foster MR, Johnson JE, Olson SJ, Allred DC (2001) Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas. Arch Pathol Lab Med 125:1316\u20131320","journal-title":"Arch Pathol Lab Med"},{"key":"340_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1534-5807(01)00022-3","volume":"1","author":"E Fuchs","year":"2001","unstructured":"Fuchs E, Merrill BJ, Jamora C, DasGupta R (2001) At the roots of a never-ending cycle. Dev Cell 1:13\u201325","journal-title":"Dev Cell"},{"key":"340_CR11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/CMR.0b013e328042bb36","volume":"17","author":"C Garbe","year":"2007","unstructured":"Garbe C, Eigentler TK (2007) Diagnosis and treatment of cutaneous melanoma: state of the art 2006. Melanoma Res 17:117\u2013127","journal-title":"Melanoma Res"},{"key":"340_CR12","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0092-8674(90)90690-G","volume":"61","author":"DA Haber","year":"1990","unstructured":"Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE (1990) An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms\u2019 tumor. Cell 61:1257\u20131269","journal-title":"Cell"},{"key":"340_CR13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0092-8674(01)00453-6","volume":"106","author":"A Hammes","year":"2001","unstructured":"Hammes A, Guo JK, Lutsch G, Leheste JR, Landrock D, Ziegler U, Gubler MC, Schedl A (2001) Two splice variants of the Wilms\u2019 tumor 1 gene have distinct functions during sex determination and nephron formation. Cell 106:319\u2013329","journal-title":"Cell"},{"key":"340_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2176\/nmc.47.165","volume":"47","author":"T Hashiba","year":"2007","unstructured":"Hashiba T, Izumoto S, Kagawa N, Suzuki T, Hashimoto N, Maruno M, Yoshimine T (2007) Expression of WT1 protein and correlation with cellular proliferation in glial tumors. Neurol Med Chir (Tokyo) 47:165\u2013170","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"340_CR15","first-page":"461","volume":"56","author":"M Herlyn","year":"1987","unstructured":"Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H (1987) Biology of tumor progression in human melanocytes. Lab Invest 56:461\u2013474","journal-title":"Lab Invest"},{"key":"340_CR16","doi-asserted-by":"crossref","first-page":"R196","DOI":"10.1093\/hmg\/ddl196","volume":"15","author":"P Hohenstein","year":"2006","unstructured":"Hohenstein P, Hastie ND (2006) The many facets of the Wilms\u2019 tumor gene WT1. Hum Mol Genet 15:R196\u2013R201","journal-title":"Hum Mol Genet"},{"key":"340_CR17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00129039-200406000-00004","volume":"12","author":"H Hwang","year":"2004","unstructured":"Hwang H, Quenneville L, Yaziji H, Gown AM (2004) Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin. Appl Immunohistochem Mol Morphol 12:122\u2013126","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"340_CR18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/modpathol.3800720","volume":"20","author":"WM Klein","year":"2007","unstructured":"Klein WM, Wu BP, Zhao S, Wu H, Klein-Szanto AJP, Tahan SR (2007) Increased expression of stem cell markers in malignant melanoma. Mod Pathol 20:102\u2013107","journal-title":"Mod Pathol"},{"key":"340_CR19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00000478-200207000-00001","volume":"26","author":"ME Lae","year":"2002","unstructured":"Lae ME, Roche PC, Jin L, Lloyd RV, Nascimento AG (2002) Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical, and molecular study of 32 tumors. Am J Surg Pathol 26:823\u2013835","journal-title":"Am J Surg Pathol"},{"key":"340_CR20","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.2741\/A341","volume":"3","author":"F Meier","year":"1998","unstructured":"Meier F, Satyamoorthy K, Nesbit M, Hsu MY, Schittek B, Garbe C, Herlyn M (1998) Molecular events in melanoma development and progression. Front Biosci 3:D1005\u2013D1010","journal-title":"Front Biosci"},{"key":"340_CR21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/modpathol.3800588","volume":"19","author":"S Nakatsuka","year":"2006","unstructured":"Nakatsuka S, Oji Y, Horiuchi T, Kanda T, Kitagawa M, Takeuchi T, Kawano K, Kuwae Y, Yamauchi A, Okumura M, Kitamura Y, Oka Y, Kawase I, Sugiyama H, Aozasa K (2006) Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 19:804\u2013814","journal-title":"Mod Pathol"},{"key":"340_CR22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/path.1711730413","volume":"173","author":"AJ Norton","year":"1994","unstructured":"Norton AJ, Jordan S, Yeomans P (1994) Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 173:371\u2013379","journal-title":"J Pathol"},{"key":"340_CR23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00000478-200004000-00016","volume":"24","author":"NG Ordonez","year":"2000","unstructured":"Ordonez NG (2000) Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Am J Surg Pathol 24:598\u2013606","journal-title":"Am J Surg Pathol"},{"key":"340_CR24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.10476","volume":"100","author":"Y Oji","year":"2002","unstructured":"Oji Y, Miyoshi S, Maeda H, Hayashi S, Tamaki H, Nakatsuka SI, Yao M, Takahashi E, Nakano Y, Hirabayashi H, Shintani Y, Oka Y, Tsuboi A, Hosen N, Asada M, Fujioka T, Murakami M, Kanato K, Motomura M, Kim EH, Kawakami M, Ikegame K, Ogawa H, Aozasa K, Kawase I, Sugiyama H (2002) Overexpression of the Wilms\u2019 tumor gene WT1 in de novo lung cancers. Int J Cancer 100:297\u2013303","journal-title":"Int J Cancer"},{"key":"340_CR25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ijc.2910590116","volume":"59","author":"U Rodeck","year":"1994","unstructured":"Rodeck U, Bossler A, Kari C, Humphreys CW, Gyorfi T, Maurer J, Thiel E, Menssen HD (1994) Expression of the WT1 Wilms\u2019 tumor gene by normal and malignant human melanocytes. Int J Cancer 59:78\u201382","journal-title":"Int J Cancer"},{"key":"340_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-1119(01)00593-5","volume":"273","author":"V Scharnhorst","year":"2001","unstructured":"Scharnhorst V, van der Eb AJ, Jochemsen AG (2001) WT1 proteins: functions in growth and differentiation. Gene 273:141\u2013161","journal-title":"Gene"},{"key":"340_CR27","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/sj.onc.1208345","volume":"24","author":"M Tuna","year":"2005","unstructured":"Tuna M, Chavez-Reyes A, Tari AM (2005) HER2\/neu increases the expression of the Wilms\u2019 tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells. Oncogene 24:1648\u20131652","journal-title":"Oncogene"},{"key":"340_CR28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.0022-202x.2001.01657.x","volume":"118","author":"EJ Gaag van der","year":"2002","unstructured":"van der Gaag EJ, Leccia MT, Dekker SK, Jalbert NL, Amodo DM, Byers HR (2002) Role of Zyxin in differential cell spreading and proliferation of melanoma cells and melanocytes. J Invest Dermatol 118:246\u2013254","journal-title":"J Invest Dermatol"},{"key":"340_CR29","first-page":"297","volume":"13","author":"KD Wagner","year":"2002","unstructured":"Wagner KD, Wagner N, Schley G, Coupland S, Heimann H, Grantyn R, Scholz H (2002) The Wilms\u2019 tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells. Cell Growth Differ 13:297\u2013305","journal-title":"Cell Growth Differ"},{"key":"340_CR30","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1242\/dev.01682","volume":"132","author":"N Wagner","year":"2005","unstructured":"Wagner N, Wagner KD, Hammes A, Kirschner KM, Vidal VP, Schedl A, Scholz H (2005) A splice variant of the Wilms\u2019 tumour suppressor Wt1 is required for normal development of the olfactory system. Development 132:1327\u20131336","journal-title":"Development"},{"key":"340_CR31","doi-asserted-by":"crossref","first-page":"R779","DOI":"10.1152\/ajpregu.00219.2006","volume":"291","author":"N Wagner","year":"2006","unstructured":"Wagner N, Wagner KD, Scholz H, Kirschner KM, Schedl A (2006) The intermediate filament protein nestin is expressed in the developing kidney and heart and might be regulated by the Wilms\u2019 tumor suppressor Wt1. Am J Physiol Regul Integr Comp Physiol 291:R779\u2013R787","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"340_CR32","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1101\/gad.346405","volume":"19","author":"N Wagner","year":"2005","unstructured":"Wagner N, Wagner KD, Theres H, Englert C, Schedl A, Scholz H (2005) Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms\u2019 tumor transcription factor Wt1. Genes Dev 19:2631\u20132642","journal-title":"Genes Dev"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-007-0340-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00424-007-0340-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-007-0340-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:28:34Z","timestamp":1629851314000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00424-007-0340-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,3]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["340"],"URL":"https:\/\/doi.org\/10.1007\/s00424-007-0340-1","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,3]]}}}